Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $12.6600 (5.76%) ($11.9800 - $12.7200) on Sun. Nov. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.95% (three month average) | RSI | 56 | Latest Price | $12.6600(5.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.2% a day on average for past five trading days. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting AUTL price | AUTL will decline at least -2.975% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.975% (StdDev 5.95%) | Hourly BBV | 0 () | Intraday Trend | 4.6% | | | |
|
5 Day Moving Average | $12.35(2.51%) | 10 Day Moving Average | $12.66(0%) | 20 Day Moving Average | $12.5(1.28%) | To recent high | -14.6% | To recent low | 29.3% | Market Cap | $N/A | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |